BCAA and Muscle Recovery: What an 18-Trial Meta-Analysis Found About Soreness and Muscle Damage

Branched-chain amino acids — leucine, isoleucine, and valine — make up about 35% of the amino acid content in muscle protein and are one of the most widely used supplements for reducing soreness and speeding recovery after intense training. A 2024 systematic review and meta-analysis in Sports Medicine – Open pooled 18 randomized controlled trials and 331 participants to test that reputation against the actual data, with a specific eye toward which recovery markers BCAA supplementation genuinely affects.

Why BCAAs, Mechanistically

Unlike most amino acids, which are broken down primarily in the liver, BCAAs are metabolized first in skeletal muscle itself — positioning them to directly influence muscle protein turnover after damage. Leucine specifically activates the mTOR signaling pathway involved in muscle protein synthesis, and BCAAs also compete with tryptophan for transport across the blood-brain barrier, a mechanism proposed to reduce serotonin-related central fatigue during and after exercise.

What 18 Trials Actually Showed

Muscle Soreness: A Clear, Consistent Effect

BCAA supplementation significantly reduced delayed onset muscle soreness (DOMS) at 24, 48, 72, and 96 hours after exercise-induced muscle damage — the effect got stronger, not weaker, over that window (largest at 72h). The one point where no significant effect showed up was immediately post-exercise, before soreness typically peaks.

Creatine Kinase: Mixed, Time-Dependent

Creatine kinase (CK), a standard blood marker of muscle cell damage, was significantly reduced immediately after exercise and again at 72 hours — but not at 24, 48, or 96 hours, a less clean pattern than the soreness results. Meta-regression found that higher total BCAA dosage and a longer supplementation period (starting before the damaging exercise, not just after) produced larger reductions in CK specifically at 48 hours.

Lactate Dehydrogenase: No Effect

BCAA supplementation showed no significant effect on lactate dehydrogenase (LDH), another muscle-damage marker, at any measured time point — the review is explicit that this is one marker BCAAs don’t move.

The Dosing Detail That Matters

Across the 18 trials, doses ranged from about 3 to 29 g/day, and the meta-regression specifically flagged two thresholds: total daily doses above roughly 5 g/day were associated with the largest soreness reduction, and supplementation periods longer than 7 days (starting before the muscle-damaging exercise, not only immediately after) produced the largest creatine kinase reduction. A single post-workout dose is a much weaker test of BCAA’s actual effect than the trial evidence supports.

The Bottom Line

The clearest, most consistent finding across this meta-analysis is that BCAA supplementation reduces perceived muscle soreness after intense exercise, with a secondary, dose- and timing-dependent effect on creatine kinase — but no effect on lactate dehydrogenase. The practical implication is that BCAA works best as a loading strategy started before a hard training block, at adequate total daily dosage, rather than a single recovery-day dose taken after the fact.

References
[1] Salem, A.; Ben Maaouai, K.; Jahrami, H.; AlMarzooqi, M.A.; Boukris, O.; Messai, B.; Clark, C.C.T.; Glenn, J.M.; Ghazzaoui, H.A.; Bragazzi, N.L.; Ammar, A.; Trabelsi, K.; Chtourou, H. “Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression.” Sports Med. Open 2024, 10, 42. https://doi.org/10.1186/s40798-024-00686-9 (open access)